ICAM1 and COVID-19: In fact, the sn/scRNA-seq data indicated that the MDA5/RAVER-ICAM1 pathway was activated in alveolar lung epithelial AT2 cells of mild-moderate COVID-19 cases in monkeys but not in those of severe COVID-19 cases in humans.